TAIGEN BIOTECHNOLOGY
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
TaiGen Biotechnology Obtains the Worldwide Rights for Nemonoxacin 2011-12-09 15:48
TaiGen Amends Global License Agreement with Warner Chilcott plc for Development and Commercialization of Nemonoxacin -- a New Generation Quinolone Antibiotic 2010-10-14 21:00
1 2